generics
Generics granted price increases
Around 60 generic medicines have been granted price increases this month, including a 133% increase for a common antibiotic Through the Generic Medicines Working Group, the Generic and Biosimilar Medicines Association …
World news wrapup: 1 September 2016
We take a look at the week in pharmacy news around the world US: Following controversy over the skyrocketing price in the US of Mylan’s EpiPen, the company has stated …
Patent dispute over generic paracetamol on hold
Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has …
Absence of more PBS reform honours commitment
The 2016 Budget confirms the significant ongoing PBS savings provided by generic medicines, and signals the government’s intent to streamline medicine regulation processes, says GBMA. The absence of further PBS …
Evergreening delays access: GBMA
Evergreening strategies delay market entry for generic medicines to the detriment of the Australian community and there is a lack of evidence to support extending market exclusivity for pharmaceuticals, according …
Apotex decision a warning bell
Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. …
Apotex pulls products as price reductions bite
Apotex has announced that it will be ceasing supply of two PBS listed prescription products from its portfolio. The PBS delisting date is yet to be confirmed, and stock will …
Generic Medicines Working Group identifies priorities
Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. …
Biosimilars: PBAC ‘a’ flags infliximab
The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …
GMiA becomes Generic and Biosimilar Medicines Association
From today, the Generic Medicines Industry Association will be known as the Generic and Biosimilar Medicines Association. After patents expire on brand name medicines, affordable generic and biosimilar medicines deliver …
Lives at stake if Trans Pacific Partnership means meds price rise
As trade ministers meet in Hawaii on 28-31 July in an effort to finalise the Trans Pacific Partnership, the Public Health Association of Australia and other stakeholders say that lives …
Pharmacies beat out supermarkets on open-seller price: Choice
Pharmacies offer overall better prices on open-selling medicines, according to a new report from Choice – as well as better customer service. Choice compared the prices of common medicines available …